Atrial fibrillation (also know as Afib) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. According to the American Heart Association, approximately 2.7 million Americans are living with Afib.
Atrial fibrillation has long been treated with the blood thinner Coumadin, also known as warfarin, which was approved by the FDA in 1954. However, new blood thinners, or anticoagulants, to treat Afib have come on the market in the last six years, including one known as Pradaxa. Continue reading